Organization | Maternal and Child Health Hospital of Hubei Province

Maternal and Child Health Hospital of Hubei Province Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Wuhan China

Organization Overview

First Clinical Trial

2015

NCT03538704

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2023

Timeline

NOW

Now

Alternative names

Maternal and Child Health Hospital of Hubei Province

Active Ingredients

Drugs in Phase 4 Trials (3)

levetiracetam (keppra) (1 trial)

phenobarbital (Luminal) (1 trial)

somatropin (protropin) (1 trial)

Drugs in Phase 2 Trials (8)

epoetin (Epogen) (1 trial)

esketamine (spravato) (2 trials)

hydromorphone (diladid) (2 trials)

propofol (diprivan) (1 trial)

remimazolam (Byfavo) (1 trial)

ropivacaine (naropin) (2 trials)

sodium chloride (1 trial)

sufentanil (2 trials)

Drugs in Other Trials (1)

metformin (glucophage) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Brain Diseases (Phase 2)

Dwarfism, Pituitary (Phase 4)

Endocrine System Diseases (Phase 4)

Premature Birth (Phase 2)

Seizures (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 8
# of Trial APIs: 12